In the quest for smooth, glowing skin, many individuals turn to anti-wrinkle injections as an effective and fast acting solution to the problem. But with the wide array of antiwrinkle products available to choose from have you ever wondered how these treatments work to deliver those results? Let's delve into the science behind two of the most popular popular anti wrinkle injectables Dysport and Xeomin, how they work, and what are the differences that make them stand out from the other options available.
First off, what are antiwrinkle injections?
All antiwrinkle injectables are made from the same original protein, Botulinum toxin type A (the original brand named itself Botox to reflect this origin). This medication works by blocking the release of acetylcholine, a neurotransmitter responsible for muscle contractions, relaxing the muscle beneath the skin and allowing the skin above to smooth itself flat and prevent the formation of deep lines. Multiple companies have since developed their own formulations of this product to join the market, all claiming that theirs is the superior option/formulation and asking for your brand loyalty.
To be completely transparent almost all of these options are perfectly effective and can be used with good success. The key to a successful treatment is correct placement, dosage, and clinical skill. In short, the most important aspect of a successful treatment is the injector. You want an experienced practitioner who is familiar with the product they are using and is able to assess your anatomy to provide a balanced and natural result that harmonises your facial features and prevents an unsatisfactory final result. However there are some differences between these products that may make you more suitable for one brand or other in particular. So lets explore two very popular brands that have been used with good success here at Encore Skin and are our products of choice.
Dysport:
Dysport is an extremely popular neuromodulator. The key difference is that the unit size is 2.5 times smaller than most other antiwrinkle types meaning you need a higher unit dose to get the same result compared to other products. However this small size means that Dysport diffuses into the muscle quickly, with many people reporting it also has a faster onset. This ability to diffuse well also makes it a popular choice for people wating it to treat a large area with fewer injection points, for instance the forehead or crows feet. So if you're not a big fan of needles then Dysport may be the choice for you.
Xeomin:
Xeomin, on the other hand, differs from Dysport and other anti wrinkle brands in that it has been through an additional refining process, making it a more pure form of Botulinum toxin type A. This means it has fewer "junk proteins" left after its extraction process. Making it less noticeable by the immune system. This decreases the likelihood of forming an immunity to antiwrinkle and can be successful treating patients who have developed resistance to other brands of antiwrinkle. This pure form of botulinum toxin also allows for a highly targeted approach to treating wrinkles and has been found to be extremely accurate in its placement. Making it very useful in areas where more accuracy and less diffusion is needed.
Longevity and Results
Both Dysport and Xeomin are found to have a competitive longevity. While individual results may vary, many individuals experience the effects of these anti-wrinkle injections for approximately three to six months. The longevity of the results depends on various factors such as metabolism, muscle activity, and treatment area.
Conclusion
All Antiwrinkle treatments provide effective treatment, as long as they are delivered by a well trained practitioner, in the correct doses, and when placed correctly. There are small differences between brand types that may make them more suitable for specific patients for instance Xeomin may be better suited to those with a potential immune resistance to Botulinum type-A, and Dysport diffuses well in the muscles allowing for large areas to be treated with fewer injection points for clients who are needle phobic.
If you would like to book in to discuss an anti wrinkle treatment with our experienced cosmetic injectors book now on line via www.encoreskin.co.nz
Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection. It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. You will need to pay for this medicine. Discuss with your specialist if Xeomin is right for you.
For more information or for a copy of CMI please contact the NZ distributor: NZMS Ltd: 2a Fisher Crescent, Mt Wellington, Auckland, Ph 09 259 4062.
DYSPORT® (Clostridium botulinum type A toxin-haemagglutinin complex, 500 IPSEN units) is a Prescription Medicine for the treatment of vertical frown lines between the eyebrows, and excessive underarm sweating. It should be administered only by trained medical professionals. DYSPORT® has risks and benefits. For more information, talk to your healthcare professional or read the Consumer Medicine Information available at www.medsafe.govt.nz. Ask your specialist if DYSPORT® is right for you. Always follow your specialist’s instructions. If you experience side effects and they concern you, see your healthcare professional. You will need to pay for DYSPORT® and for the administration and consultation charges. Galderma c/o Healthcare Logistics 58 Richard Pearse Drive Airport Oaks, Auckland, New Zealand.
Comments